Literature DB >> 23851836

Orbital apex syndrome as a sign of unsuspected breast carcinoma.

Abdulkadir Imre1, E Umut Sakarya, Seher Sartepe Imre, Onur Gundogan, Nezahat Erdogan, Turkan Rezanko.   

Abstract

Breast cancer, the most common form of cancer among women, rarely metastasizes to the paranasal sinuses and skull base. The disease usually proceeds insidiously, remaining asymptomatic until ocular symptoms appear. Orbital involvement is frequently seen in metastatic disease of the paranasal sinuses and skull base, but orbital apex syndrome is rare. Early presentation with clinical features of acute ethmoiditis can delay the diagnosis of metastatic disease. Here, we report the case of a 43-year-old woman with breast cancer who presented with orbital apex syndrome secondary to the skull base and paranasal sinus metastasis.

Entities:  

Mesh:

Year:  2013        PMID: 23851836     DOI: 10.1097/SCS.0b013e3182903384

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

Review 1.  Neoplastic nerve lesions.

Authors:  Deep K Patel; Kelly G Gwathmey
Journal:  Neurol Sci       Date:  2022-02-23       Impact factor: 3.830

2.  Ethmoidal metastasis as a first presentation of breast cancer: a case report.

Authors:  A Maity; E Maughan; S Vasani; G Alusi
Journal:  Ann R Coll Surg Engl       Date:  2018-04-01       Impact factor: 1.891

3.  Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review.

Authors:  Jie Xiong; Jing Chen; Liduan Zheng; Shengli Yang; Guifang Zhao; Jing Cheng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 4.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.